Patients with a high GLO1 expression had a significantly shorter progression-free and disease-specific survival, suggesting a critical role of GLO1 activity not only in the initiation and maintenance of malignant tumor growth, but also the invasive capacity and metastatic spread of OPSCC tumor cells. The gene discussed is GLO1; the disease is cancer.